AbbVie: Berenberg raises target price to $305 from $275
ABBV•Berenberg raised its target price for AbbVie to $305 from $275.
Related News
BioVersys to present Phase 2 alpibectir-ethionamide data in tuberculosis patients
GSK•
Dollar strength weighs on Asian FX; AI stocks extend gains
TLT•
Western Union terminates Intermex deal after approval snag
IMXI•
ITG management commentary attributes Q3 2026 revenue growth of 49% to higher maintenance and deployment activity
ITG•
Palomar Holdings publishes third-quarter 2026 earnings call transcript
PLMR•